CPAR Uganda Ltd

facebook twitter 

Tuberculosis Treatment Drugs Uganda’s Greater Northern Region

This is the third in a series of briefings on research findings that CPAR Uganda Ltd (CPAR) is publishing in order to share the findings of its empirical qualitative investigation in to pulmonary tuberculosis (PTB) in Uganda.

CPAR’s briefing number three contains an analysis of its findings on availability and accessibility of PTB treatment drugs in the greater northern region of Uganda, including: Karamoja, Lango, Acholi and West Nile sub-regions. And it is also contains an analysis of CPAR’s findings on the completion rates of PTB treatment in the greater northern Uganda.

CPAR conducted its qualitative investigation into TB in Uganda as part of the TWENDE research and advocacy project that was funded by the EDCTP, under its second programme, EDCTP2, that was funded by Horizon 2020 European Union Funding for Research and innovations.

The full PDF of the brief is available to download here, free of charge.

Image credit: LGC Publishing


Tuberculosis: Working to Empower the Nations’ Diagnostic Efforts (TWENDE)
Disclaimer: This is among the products of the TWENDE project that is part of the EDCTP2 programme supported by the European Union.  Whereas, the EDCTP Association and the European Union provided funding for the TWENDE Project, the views herein expressed are not necessarily those of the EDCTP Association or those of the European Union.